{"id":"tp-57016","type":"article-newspaper","title":"Inhibrx Biosciences Reported $36.7 Million Q2 Loss on Aug. 13","author":"John Kim","publisher":"TOKENPOST Inc.","url":"https://www.tokenpost.com/news/business/57016","datePublished":"2026-11-13T21:19:15.000Z","dateModified":"2026-11-13T21:19:15.000Z","language":"en","abstract":"Revenue was $0, compared with $1.3 million in the second quarter of 2025; the company recorded a $2.34 loss per share.","section":"Business","references":[]}